Penta Labs Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.88 M
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -22.91%
- Ebitda -23.16%
- Net Worth -4021.25%
- Total Assets -22.93%
About Penta Labs
Penta Labs Private Limited (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 November 2006 and has a history of 18 years and two months. Its registered office is in Palakkad, Kerala.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.88 M, as per Ministry of Corporate Affairs (MCA) records.
Bhat Sambhu, Vijayasree, and Variketta Namboodiri serve as directors at the Company.
Company Details
-
LocationPalakkad, Kerala
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232KL2006PTC019998
-
Company No.
019998
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Nov 2006
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Penta Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijayasree
|
Managing Director | 09-Mar-2012 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Bhat Sambhu
|
Director | 13-Nov-2006 | Current |
|
Variketta Namboodiri
|
Additional Director | 09-Mar-2012 | Current |
Financial Performance of Penta Labs.
Penta Labs Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 22.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 4021.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Penta Labs?
In 2019, Penta Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Systa Pharma Labs Private LimitedBhat Sambhu, Vijayasree and 1 more are mutual person
-
Vintanova Pharma Private LimitedBhat Sambhu, Vijayasree and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Penta Labs?
Unlock and access historical data on people associated with Penta Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Penta Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Penta Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
